CINCINNATI--(BUSINESS WIRE)-- Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2024. Stockholders also approved Chemed’s executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 40 cents per share on the ...
Moody's Ratings (Moody's) today assigned a Baa3 rating to Entergy Corporation's (Entergy) (Baa2 stable) Junior Subordinated Debentures. The outlook for Entergy is stable. RATINGS RATIONALE The Baa3 rating assigned to Entergy's Junior Subordinated Debentures reflects the security's relative posit...
MURRIETA, Calif.--(BUSINESS WIRE)-- , a division of , announced the sale of Silverado Apartment Homes, a 492-unit multifamily property in Murrieta, California. The property sold for $146.5 million, which equates to $297,764 per unit. “Silverado presented a unique opportunity to acquire a newer vintage Inland Empire asset with substantial upside in a burgeoning submarket with strong fundamentals,” said Kevin Green, IPA executive managing director investments. “Our controlled process was met with a positive response and yielded a highly competitive sales environment. The opportunity was bolste...
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1 Antitrypsin Deficiency (AATD) mouse modelKRRO-110 showed 35µM of M-AAT one week post the first dose, with 0µM of M-AAT at baseline, increasing to 45µM of M-AAT at week 13 CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical com...
PARIS--(BUSINESS WIRE)-- Regulatory News: Dans le cadre de l’autorisation consentie par l’Assemblée Générale mixte du 16 mai 2024 pour la mise en œuvre d’un programme de rachat d’actions, Axway Software SA (Paris:AXW) (LEI : 96950022O6SP7FQONJ77) déclare ci-après les achats d’actions propres (FR0011040500) réalisés du 13 au 17 mai 2024 : Jour de latransaction Volume total journalier(nombre de titres) Prix pondérémoyen d'acquisition(€/action) Montant destransactions(€) Code identifiantmarché 13/05/2024 810 24.99 20,241 XPAR 14/05/2024 733 24.73 18,1...
Moody's Ratings (Moody's) assigned an A3 rating to PayPal Holdings, Inc.'s (PayPal) proposed senior unsecured notes. The ratings outlook is stable. The net proceeds of the offering will be used for general corporate purposes including prefunding senior notes maturing October 1, 2024. RATINGS RATIO...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammationData support the potential of Dupixent as the first new treatment approach in mo...
Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Les résultats de l’étude NOTUS confirment les données décisives de l’étude de phase III BOREAS et montrent que, dans le traitement de la bronchopneumopathie chronique obstructive (BPCO) avec signature inflammatoire de ty...
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammation Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD TARRYTOWN, N.Y. and PARIS...
A director at Xianhe Co Ltd maiden bought 1,110,000 shares at 19.853CNY and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
HP Unlocks New Era of AI Experiences Powering Work and Creation World’s most powerful and secure ultra-mobile AI PCs drive next generation of AI computing with record-breaking 26 hours of battery life 1, 2, 3 News Highlights: World’s most powerful ultra-mobile next-gen AI PCs1 reclaim time for meaningful work and creationUnleash your full potential from anywhere with the world’s longest battery life in an ultra-mobile next-gen AI PC3Sleek new HP next-gen AI PCs deliver lightning-fast responsiveness with a dedicated NPU4 capable of 45 trillion operations per second (TOPS)Discover new AI su...
Moody's Ratings (Moody's) has assigned a Ba3 rating to PennyMac Financial Services, Inc.'s (PFSI) proposed $650 million backed long-term senior unsecured notes maturing 2030. The notes will be guaranteed on an unsecured basis by each of PFSI's existing and future domestic subsidiaries, including Pri...
Moody's Ratings ("Moody's") has affirmed A1/VMIG 1 rating assigned to The Health, Educational and Housing Facility Board of the County of Shelby, Tennessee Variable Rate Revenue Bonds, Series 2008A (Methodist Le Bonheur Healthcare) ("Series 2008A") and Variable Rate Revenue Bonds, Series 2008B (Meth...
Moody's Ratings (Moody's) has upgraded Adams & Hancock Counties Community Unit School District 4 (Mendon), IL's issuer and general obligation unlimited tax (GOULT) ratings to A1 from A2. The district had roughly six million in debt outstanding as of June 30, 2023. The upgrade to A1 is driven by gr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.